Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Price, Quote, News and Overview

FRA:FRE - Deutsche Boerse Ag - DE0005785604 - Common Stock - Currency: EUR

38.93  +2.37 (+6.48%)

FRE.DE Quote, Performance and Key Statistics

FRESENIUS SE & CO KGAA

FRA:FRE (2/26/2025, 5:35:30 PM)

38.93

+2.37 (+6.48%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High38.48
52 Week Low24.32
Market Cap21.93B
Shares563.24M
Float411.39M
Yearly Dividend1.59
Dividend Yield3.29%
PE36.05
Fwd PE11.78
Earnings (Next)02-26 2025-02-26/amc
IPO12-18 1986-12-18


FRE.DE short term performance overview.The bars show the price performance of FRE.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 6 8

FRE.DE long term performance overview.The bars show the price performance of FRE.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of FRE.DE is 38.93 EUR. In the past month the price decreased by -1.54%. In the past year, price increased by 41.71%.

FRESENIUS SE & CO KGAA / FRE Daily stock chart

FRE.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
1CVS.MI CVS HEALTH CORP 11.73 76.15B
CVS.DE CVS HEALTH CORP 11.67 75.81B
FME.DE FRESENIUS MEDICAL CARE AG 16.1 26.45B
V3V.DE FAMICORD AG 29.86 73.74M

About FRE.DE

Company Profile

FRE logo image Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,091 full-time employees. The company operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. The company also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. The company also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.

Company Info

FRESENIUS SE & CO KGAA

Else-Kroener-Str. 1

BAD HOMBURG HESSEN DE

Employees: 175771

Company Website: https://www.fresenius.com/

Investor Relations: https://www.fresenius.com/investors

Phone: 4961726080

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the stock price of FRESENIUS SE & CO KGAA today?

The current stock price of FRE.DE is 38.93 EUR. The price increased by 6.48% in the last trading session.


What is the ticker symbol for FRESENIUS SE & CO KGAA stock?

The exchange symbol of FRESENIUS SE & CO KGAA is FRE and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is FRE.DE stock listed?

FRE.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for FRESENIUS SE & CO KGAA stock?

24 analysts have analysed FRE.DE and the average price target is 42.21 EUR. This implies a price increase of 8.43% is expected in the next year compared to the current price of 38.93. Check the FRESENIUS SE & CO KGAA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FRESENIUS SE & CO KGAA worth?

FRESENIUS SE & CO KGAA (FRE.DE) has a market capitalization of 21.93B EUR. This makes FRE.DE a Large Cap stock.


How many employees does FRESENIUS SE & CO KGAA have?

FRESENIUS SE & CO KGAA (FRE.DE) currently has 175771 employees.


What are the support and resistance levels for FRESENIUS SE & CO KGAA (FRE.DE) stock?

FRESENIUS SE & CO KGAA (FRE.DE) has a support level at 35.8 and a resistance level at 36.67. Check the full technical report for a detailed analysis of FRE.DE support and resistance levels.


Is FRESENIUS SE & CO KGAA (FRE.DE) expected to grow?

The Revenue of FRESENIUS SE & CO KGAA (FRE.DE) is expected to decline by -22.33% in the next year. Check the estimates tab for more information on the FRE.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FRESENIUS SE & CO KGAA (FRE.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FRESENIUS SE & CO KGAA (FRE.DE) stock pay dividends?

FRESENIUS SE & CO KGAA (FRE.DE) has a dividend yield of 3.29%. The yearly dividend amount is currently 1.59. Check the full fundamental report for a detailed analysis of FRE.DE dividend history, reliability and sustainability.


When does FRESENIUS SE & CO KGAA (FRE.DE) report earnings?

FRESENIUS SE & CO KGAA (FRE.DE) will report earnings on 2025-02-26, after the market close.


What is the Price/Earnings (PE) ratio of FRESENIUS SE & CO KGAA (FRE.DE)?

The PE ratio for FRESENIUS SE & CO KGAA (FRE.DE) is 36.05. This is based on the reported non-GAAP earnings per share of 1.08 and the current share price of 38.93 EUR. Check the full fundamental report for a full analysis of the valuation metrics for FRE.DE.


FRE.DE Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to FRE.DE. When comparing the yearly performance of all stocks, FRE.DE is one of the better performing stocks in the market, outperforming 92.48% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FRE.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE. FRE.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FRE.DE Financial Highlights

Over the last trailing twelve months FRE.DE reported a non-GAAP Earnings per Share(EPS) of 1.08. The EPS increased by 30.12% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.9%
ROE -2.03%
Debt/Equity 0.61
Chartmill High Growth Momentum
EPS Q2Q%195.83%
Sales Q2Q%-2.75%
EPS 1Y (TTM)30.12%
Revenue 1Y (TTM)-41.63%

FRE.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to FRE.DE. The Buy consensus is the average rating of analysts ratings from 24 analysts.

For the next year, analysts expect an EPS growth of 655.38% and a revenue growth -22.33% for FRE.DE


Ownership
Inst Owners42.21%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts83.33
Price Target42.21 (8.43%)
EPS Next Y655.38%
Revenue Next Year-22.33%